For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260105:nRSE5423Na&default-theme=true
RNS Number : 5423N CVS Group plc 05 January 2026
05 January 2026
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 02 January 2026 it purchased the following number of its
ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 02/01/2026
Aggregate number of Ordinary Shares purchased: 15,144
Lowest price paid per share (GBp): 1,276.00
Highest price paid per share (GBp): 1,288.00
Volume weighted average price paid per share (GBp): 1,283.48
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,691,575 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,691,575 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,049,208 Ordinary Shares in aggregate at a weighted average price
of 1,222.17 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
476 1286 02/01/2026 08:32:57 1363214713492077 XLON
68 1288 02/01/2026 08:36:55 1363214713492337 XLON
369 1288 02/01/2026 08:41:48 1363214713492824 XLON
100 1286 02/01/2026 08:50:09 1363214713493401 XLON
96 1286 02/01/2026 09:04:15 1363214713495427 XLON
68 1278 02/01/2026 09:40:47 1363214713497964 XLON
190 1280 02/01/2026 10:10:30 1363214713499744 XLON
255 1280 02/01/2026 10:10:30 1363214713499745 XLON
74 1278 02/01/2026 10:10:49 1363214713499776 XLON
100 1278 02/01/2026 10:10:49 1363214713499777 XLON
68 1278 02/01/2026 10:40:53 1363214713501159 XLON
390 1276 02/01/2026 12:51:49 1363214713506596 XLON
44 1276 02/01/2026 12:56:38 1363214713506780 XLON
48 1276 02/01/2026 12:56:38 1363214713506781 XLON
134 1276 02/01/2026 12:56:38 1363214713506782 XLON
185 1276 02/01/2026 13:00:42 1363214713506895 XLON
313 1276 02/01/2026 13:51:36 1363214713509932 XLON
100 1276 02/01/2026 13:51:36 1363214713509933 XLON
100 1276 02/01/2026 13:51:36 1363214713509931 XLON
17 1276 02/01/2026 13:51:36 1363214713509930 XLON
9 1276 02/01/2026 13:51:36 1363214713509929 XLON
179 1276 02/01/2026 13:51:36 1363214713509928 XLON
176 1276 02/01/2026 13:51:36 1363214713509934 XLON
176 1276 02/01/2026 13:51:36 1363214713509935 XLON
176 1276 02/01/2026 13:51:36 1363214713509936 XLON
126 1276 02/01/2026 13:51:36 1363214713509937 XLON
35 1276 02/01/2026 13:51:36 1363214713509938 XLON
161 1276 02/01/2026 13:51:36 1363214713509940 XLON
15 1276 02/01/2026 13:51:36 1363214713509939 XLON
176 1276 02/01/2026 13:51:36 1363214713509941 XLON
20 1276 02/01/2026 13:51:36 1363214713509942 XLON
156 1276 02/01/2026 13:51:36 1363214713509943 XLON
74 1276 02/01/2026 13:51:36 1363214713509944 XLON
86 1276 02/01/2026 13:51:36 1363214713509945 XLON
313 1276 02/01/2026 13:51:36 1363214713509947 XLON
16 1276 02/01/2026 13:51:36 1363214713509946 XLON
25 1276 02/01/2026 13:51:38 1363214713509952 XLON
55 1280 02/01/2026 14:28:25 1363214713512594 XLON
212 1284 02/01/2026 14:31:19 1363214713513356 XLON
3 1284 02/01/2026 14:46:05 1363214713516114 XLON
560 1284 02/01/2026 14:46:05 1363214713516115 XLON
381 1284 02/01/2026 14:56:31 1363214713517481 XLON
179 1284 02/01/2026 14:56:31 1363214713517482 XLON
411 1284 02/01/2026 15:01:46 1363214713518218 XLON
152 1284 02/01/2026 15:01:46 1363214713518219 XLON
200 1284 02/01/2026 15:12:32 1363214713519639 XLON
68 1284 02/01/2026 15:16:36 1363214713520188 XLON
576 1284 02/01/2026 15:24:08 1363214713521316 XLON
576 1284 02/01/2026 15:24:08 1363214713521317 XLON
431 1284 02/01/2026 15:38:58 1363214713522993 XLON
131 1284 02/01/2026 15:38:58 1363214713522994 XLON
103 1286 02/01/2026 15:48:01 1363214713523863 XLON
219 1286 02/01/2026 15:48:01 1363214713523862 XLON
170 1286 02/01/2026 15:48:01 1363214713523861 XLON
127 1286 02/01/2026 15:48:01 1363214713523860 XLON
176 1286 02/01/2026 15:48:01 1363214713523864 XLON
176 1286 02/01/2026 15:48:01 1363214713523865 XLON
176 1286 02/01/2026 15:48:01 1363214713523866 XLON
176 1288 02/01/2026 15:49:29 1363214713523986 XLON
176 1288 02/01/2026 15:49:29 1363214713523987 XLON
176 1288 02/01/2026 15:49:29 1363214713523988 XLON
176 1288 02/01/2026 15:49:29 1363214713523989 XLON
176 1288 02/01/2026 15:49:29 1363214713523990 XLON
176 1288 02/01/2026 15:49:29 1363214713523991 XLON
176 1288 02/01/2026 15:49:29 1363214713523992 XLON
27 1288 02/01/2026 15:49:29 1363214713523993 XLON
27 1288 02/01/2026 15:49:29 1363214713523995 XLON
149 1288 02/01/2026 15:49:29 1363214713523994 XLON
176 1288 02/01/2026 15:49:29 1363214713523996 XLON
176 1288 02/01/2026 15:49:29 1363214713523997 XLON
66 1288 02/01/2026 15:49:29 1363214713523998 XLON
569 1286 02/01/2026 15:49:29 1363214713524000 XLON
496 1284 02/01/2026 16:06:21 1363214713526638 XLON
89 1288 02/01/2026 16:23:18 1363214713529369 XLON
176 1288 02/01/2026 16:23:18 1363214713529370 XLON
176 1288 02/01/2026 16:23:18 1363214713529371 XLON
176 1288 02/01/2026 16:23:18 1363214713529372 XLON
4 1288 02/01/2026 16:23:18 1363214713529373 XLON
172 1288 02/01/2026 16:23:18 1363214713529374 XLON
77 1288 02/01/2026 16:23:18 1363214713529375 XLON
99 1288 02/01/2026 16:23:18 1363214713529376 XLON
176 1288 02/01/2026 16:23:18 1363214713529377 XLON
176 1288 02/01/2026 16:23:18 1363214713529378 XLON
176 1288 02/01/2026 16:23:18 1363214713529379 XLON
70 1288 02/01/2026 16:23:18 1363214713529380 XLON
176 1288 02/01/2026 16:23:18 1363214713529381 XLON
176 1288 02/01/2026 16:23:21 1363214713529406 XLON
111 1288 02/01/2026 16:23:22 1363214713529409 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial
PR)
cvsg@camarco.co.uk
Ginny Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPUMWGUPQGMP
Copyright 2019 Regulatory News Service, all rights reserved